Grantham Foundation — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Napigennapigen.comin𝕏Jul 2022 · $7.9M
Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.
AgTechBiotechWilmington, US
Co-investorsThe Innovation SpaceMarsBioRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.